Simon Property Group (SPG)

Total Liabilities

$34.13B

Quarterly · Period ending: · USD

SPG logo

SPG Total Liabilities

Latest reported$34.13B
SPG Quarterly Total Liabilities ($1.73B → $34.13B)
High-resolution chart · PNG

SPG total liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Simon Property Group Total Liabilities — Quarterly (USD)
Period endingTotal Liabilities (USD)
34,134,500,000
33,302,299,000
33,901,073,000
30,627,651,000
30,204,532,000
29,233,568,000
28,806,239,000
29,953,682,000
29,790,258,000
29,934,567,000
30,595,897,000
29,351,729,000
29,291,766,000
29,620,505,000
29,187,383,000
28,758,802,000
28,982,034,000
29,160,555,000
29,376,654,000
29,518,422,000
30,613,003,000
30,383,970,000
31,128,608,000
29,458,166,000
31,503,339,000
31,397,967,000
28,101,319,000
30,537,187,000
27,137,918,000
26,915,952,000
26,659,104,000
26,984,255,000
26,766,511,000
26,782,844,000
27,828,394,000
26,603,072,000
26,490,428,000
26,050,241,000
26,005,904,000
26,182,685,000
25,904,970,000
25,880,427,000
25,408,767,000
25,495,387,000
24,878,845,000
24,484,927,000
23,555,288,000
23,779,971,000
24,445,269,000
25,783,706,000
26,311,457,000
25,127,124,000
25,028,872,000
24,875,433,000
25,515,511,000
25,156,936,000
24,855,984,000
25,123,931,000
20,672,637,000
20,063,198,000
18,964,921,000
19,009,206,000
19,223,677,000
19,180,425,000
18,599,115,000
19,835,749,000
20,765,304,000
20,875,631,000
20,084,347,000
19,612,948,000
20,556,489,000
20,451,184,000
20,287,417,000
19,079,210,000
19,003,160,000
18,811,699,000
17,973,187,000
18,671,036,000
16,909,517,000
15,691,793,000
15,511,677,000
15,516,453,000
15,958,178,000
15,723,553,000
15,538,848,000
15,735,118,000
16,049,369,000
11,975,658,000
11,982,029,000
11,294,924,000
11,228,824,000
10,827,247,000
10,471,246,000
10,538,342,000
10,412,992,000
10,126,194,000
10,268,017,000
9,505,133,000
9,628,915,000
9,450,317,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.